SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (284401)12/2/2015 9:23:47 PM
From: Sam  Read Replies (1) | Respond to of 541851
 
Can't you get another prescription drug plan?

So many people have diabetes, one would think that economies of scale would lower the cost of insulin instead of it going up.

But of course cost has nothing to do with it, as far as the drug companies are concerned.



To: bentway who wrote (284401)12/2/2015 10:21:42 PM
From: Ron  Respond to of 541851
 
You can thank Billy Tauzin who was a key negotiator in putting together Medicare Drug coverage. Congress specifically prevented the Federal Government from negotiating with drug makers on prices. Tauzin of course later went on to work for the drug manufacturers as a lobbyist. Drug coverage is a weak link for sure.

In hindsight...when they put through that lousy drug coverage deal, investing in the pharma sector would have
paid for a lotta drugs.

stockcharts.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News